Cargando…

An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort

The Viking Health Study Shetland is a population-based research cohort of 2,122 volunteer participants with ancestry from the Shetland Isles in northern Scotland. The high kinship and detailed phenotype data support a range of approaches for associating rare genetic variants, enriched in this isolat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerr, Shona M., Klaric, Lucija, Halachev, Mihail, Hayward, Caroline, Boutin, Thibaud S., Meynert, Alison M., Semple, Colin A., Tuiskula, Annukka M., Swan, Heikki, Santoyo-Lopez, Javier, Vitart, Veronique, Haley, Chris, Dean, John, Miedzybrodzka, Zosia, Aitman, Timothy J., Wilson, James F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662790/ https://www.ncbi.nlm.nih.gov/pubmed/31358886 http://dx.doi.org/10.1038/s41598-019-47436-6

Ejemplares similares

Increased ultra-rare variant load in an isolated Scottish population impacts exonic and regulatory regions
por: Halachev, Mihail, et al.
Publicado: (2019)

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients: Koponen et al. Follow-up of adult LQTS patients
por: Koponen, Mikael, et al.
Publicado: (2018)

KCNE1 D85N polymorphism — a sex-specific modifier in type 1 long QT syndrome?
por: Lahtinen, Annukka M, et al.
Publicado: (2011)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
por: Fujisawa, Taishi, et al.
Publicado: (2020)

Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2
por: Sawyer, Briana L., et al.
Publicado: (2020)

Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation
por: Koponen, Mikael, et al.
Publicado: (2020)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians
por: Kerr, Shona M., et al.
Publicado: (2023)

Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome
por: Aizawa, Takanori, et al.
Publicado: (2023)

Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation
por: Mihic, Anton, et al.
Publicado: (2011)

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene
por: Giustetto, Carla, et al.
Publicado: (2015)

VIKING II, a worldwide observational cohort of volunteers with northern isles ancestry
por: Kerr, Shona M., et al.
Publicado: (2023)

Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers
por: Haapalahti, Petri, et al.
Publicado: (2011)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report
por: Caiffa, Thomas, et al.
Publicado: (2022)

Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol
por: Zhang, Shugang, et al.
Publicado: (2022)

Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing
por: Fazelifar, Amir Farjam, et al.
Publicado: (2023)

KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences
por: Ke, ZunPing, et al.
Publicado: (2023)

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2
por: Christiansen, Michael, et al.
Publicado: (2014)

Colocalization of corneal resistance factor GWAS loci with GTEx e/sQTLs highlights plausible candidate causal genes for keratoconus postnatal corneal stroma weakening
por: Jiang, Xinyi, et al.
Publicado: (2023)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Novel KCNH1 Mutations Associated with Epilepsy: Broadening the Phenotypic Spectrum of KCNH1-Associated Diseases
por: von Wrede, Randi, et al.
Publicado: (2021)

A Novel KCNH2 S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
por: Cheng, Yu-Wen, et al.
Publicado: (2023)

Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes
por: Kekenes-Huskey, Peter M., et al.
Publicado: (2022)

Long QT syndrome in chromosome 7q35q36.3 deletion involving KCNH2 gene: Warning for chlorpheniramine prescription
por: Di Stolfo, Giuseppe, et al.
Publicado: (2019)

Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early‐onset long QT syndrome and sinoatrial node dysfunction
por: Yang, Zhe, et al.
Publicado: (2021)

KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort
por: Lorca, Rebeca, et al.
Publicado: (2022)

Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations
por: Zhang, Xianqin, et al.
Publicado: (2008)

Dynamic rearrangement of the intrinsic ligand regulates KCNH potassium channels
por: Dai, Gucan, et al.
Publicado: (2018)

Application of Multigene Panel Sequencing in Patients with Prolonged Rate-corrected QT Interval and No Pathogenic Variants Detected in KCNQ1, KCNH2, and SCN5A
por: Seo, Soo Hyun, et al.
Publicado: (2018)

The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era
por: Kounidas, Georgios, et al.
Publicado: (2021)

Structure of the C-terminal Region of a KCNH Channel
por: Brelidze, Tinatin I., et al.
Publicado: (2012)

The structural mechanism of KCNH-channel regulation by the eag domain
por: Haitin, Yoni, et al.
Publicado: (2013)

Is KCNH1 mutation related to coronary artery ectasia
por: Noori, Mohammad Rafi, et al.
Publicado: (2019)

Clinical Feature, Treatment, and KCNH5 Mutations in Epilepsy
por: Hu, Xiufu, et al.
Publicado: (2022)

Structural Modelling of KCNQ1 and KCNH2 Double Mutant Proteins, Identified in Two Severe Long QT Syndrome Cases, Reveals New Insights into Cardiac Channelopathies
por: Agudelo, William A., et al.
Publicado: (2021)

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia
por: Marjamaa, Annukka, et al.
Publicado: (2009)

Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants
por: Nagy, Reka, et al.
Publicado: (2017)

Structural Properties of PAS Domains from the KCNH Potassium Channels
por: Adaixo, Ricardo, et al.
Publicado: (2013)

Molecular mechanism of voltage-dependent potentiation of KCNH potassium channels
por: Dai, Gucan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aufsftv2t0dub096phoi1ivqpk